Download PDF
J Knee Surg 2022; 35(14): 1511-1517
DOI: 10.1055/s-0042-1757596
Special Focus Section

Delaying Total Knee Arthroplasty More than 4 Weeks after Intra-Articular Knee Injection Does Not Further Decrease Risk of Septic Revision

Sandeep S. Bains
1   LifeBridge Health, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland
,
Zhongming Chen 
1   LifeBridge Health, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland
,
Oliver C. Sax
1   LifeBridge Health, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland
,
Qais Naziri
2   SUNY Downstate Medical Center, Department of Orthopaedic Surgery, Brooklyn, New York
,
James Nace
1   LifeBridge Health, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland
,
Ronald E. Delanois 
1   LifeBridge Health, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Hyaluronic acid (HA) and corticosteroid (CS) injections are utilized in symptom management for patients with osteoarthritis. However, contamination of the joint may increase the risk of infection following total knee arthroplasty (TKA). Therefore, the purpose of this study was to examine 90-day surgical site infection (SSI) and manipulation under anesthesia (MUA) as well as up to 2-year prosthetic joint infection (PJI) in intra-articular knee injection recipients prior to TKA compared with patients who did not have knee injections. We specifically assessed (1) timing of HA and CS prior to TKA; (2) type of intra-articular knee injection; as well as (3) associated risk factors. We queried a national database to identify patients who underwent primary TKA from September 2015 to October 2020 (n = 1.5 million). Patients with prior knee injections were stratified to five cohorts: HA within 4 weeks (n = 140), HA 4 to 6 weeks prior (n = 337), CS within 4 weeks (n = 2,344), CS 4 to 6 weeks (n = 2,422), and a no injection, control, cohort prior to TKA (n = 5,000). Bivariate chi-square analyses of outcomes were conducted, and multivariate regressions were used to adjust for comorbidities and assess associated risk factors. The adjusted analysis showed a significant risk in infection for patients receiving an injection within 4 weeks of TKA (p < 0.023) and showed no difference in type of injection (p > 0.050). Additionally, SSIs were increased 1.58 times in the CS within 4 weeks of TKA cohort (p = 0.023). However, no difference in MUA risk was shown at 90-day postoperative (p > 0.212). Furthermore, tobacco use was identified as a risk factor that further increased likelihood of PJI. Intra-articular knee injection less than 4 weeks before TKA increased the risk for PJI; however, past 4 weeks did not confer infection risk. Tobacco use was identified as an associated risk factor that further increased likelihood for PJI. These results highlight the need for surgeons to wait 4 weeks between knee injection and TKA to decrease risk of septic revision.

Keywords

injection - TKA - infection - corticosteroid - hyaluronic acid


Publication History

Received: 22 July 2022

Accepted: 26 August 2022

Article published online:
20 December 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Sharkey PF, Lichstein PM, Shen C, Tokarski AT, Parvizi J. Why are total knee arthroplasties failing today–has anything changed after 10 years?. J Arthroplasty 2014; 29 (09) 1774-1778
    CrossrefPubMedGoogle Scholar
  • 2 Delanois RE, Mistry JB, Gwam CU, Mohamed NS, Choksi US, Mont MA. Current epidemiology of revision total knee arthroplasty in the United States. J Arthroplasty 2017; 32 (09) 2663-2668
    CrossrefPubMedGoogle Scholar
  • 3 Lawson KA, Chen AF, Springer BD. et al. Migration patterns for revision total knee arthroplasty in the United States as reported in the American Joint Replacement Registry. J Arthroplasty 2021; 36 (10) 3538-3542
    CrossrefPubMedGoogle Scholar
  • 4 Kurtz SM, Lau EC, Son M-S, Chang ET, Zimmerli W, Parvizi J. Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the Medicare population. J Arthroplasty 2018; 33 (10) 3238-3245
    CrossrefPubMedGoogle Scholar
  • 5 Matar WY, Jafari SM, Restrepo C, Austin M, Purtill JJ, Parvizi J. Preventing infection in total joint arthroplasty. J Bone Joint Surg Am 2010; 92 (Suppl. 02) 36-46
    CrossrefPubMedGoogle Scholar
  • 6 Parvizi J, Shohat N, Gehrke T. Prevention of periprosthetic joint infection: new guidelines. Bone Joint J 2017; 99-B (4, supple B): 3-10
    CrossrefPubMedGoogle Scholar
  • 7 Bannuru RR, Osani MC, Vaysbrot EE. et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 2019; 27 (11) 1578-1589
    Google Scholar
  • 8 Kolasinski SL, Neogi T, Hochberg MC. et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2020; 72 (02) 149-162
    CrossrefPubMedGoogle Scholar
  • 9 Amin NH, Omiyi D, Kuczynski B, Cushner FD, Scuderi GR. The risk of a deep infection associated with intraarticular injections before a total knee arthroplasty. J Arthroplasty 2016; 31 (01) 240-244
    CrossrefPubMedGoogle Scholar
  • 10 Bedard NA, Pugely AJ, Elkins JM. et al. The John N. Insall Award: do intraarticular injections increase the risk of infection after TKA?. Clin Orthop Relat Res 2017; 475 (01) 45-52
    CrossrefPubMedGoogle Scholar
  • 11 Cancienne JM, Werner BC, Luetkemeyer LM, Browne JA. Does timing of previous intra-articular steroid injection affect the post-operative rate of infection in total knee arthroplasty?. J Arthroplasty 2015; 30 (11) 1879-1882
    CrossrefPubMedGoogle Scholar
  • 12 Marsland D, Mumith A, Barlow IW. Systematic review: the safety of intra-articular corticosteroid injection prior to total knee arthroplasty. Knee 2014; 21 (01) 6-11
    CrossrefPubMedGoogle Scholar
  • 13 Kurtz SM, Mont MA, Chen AF. et al. Intra-articular corticosteroid or hyaluronic acid injections are not associated with periprosthetic joint infection risk following total knee arthroplasty. J Knee Surg 2022; 35 (09) 983-996
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Grondin J, Menu P, Métayer B, Crenn V, Dauty M, Fouasson-Chailloux A. Intra-articular injections prior to total knee arthroplasty do not increase the risk of periprosthetic joint infection: a prospective cohort study. Antibiotics (Basel) 2021; 10 (03) 330
    CrossrefPubMedGoogle Scholar
  • 15 Richardson SS, Schairer WW, Sculco TP, Sculco PK. Comparison of infection risk with corticosteroid or hyaluronic acid injection prior to total knee arthroplasty. J Bone Joint Surg Am 2019; 101 (02) 112-118
    CrossrefPubMedGoogle Scholar
  • 16 Bhattacharjee S, Wallace S, Luu HH, Shi LL, Lee MJ, Chen AF. Do we need to wait 3 months after corticosteroid injections to reduce the risk of infection after total knee arthroplasty?. J Am Acad Orthop Surg 2021; 29 (14) e714-e721
    CrossrefPubMedGoogle Scholar
  • 17 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
    CrossrefPubMedGoogle Scholar
  • 18 Nie F, Li W. Impact of prior intra-articular injections on the risk of prosthetic joint infection following total joint arthroplasty: a systematic review and meta-analysis. Front Surg 2021; 8: 737529
    CrossrefPubMedGoogle Scholar
  • 19 Rao PS. Corticosteroids. In: Encyclopedia of Toxicology. Amsterdam, Netherlands: Elsevier; 2005: 669-670
    Google Scholar
  • 20 Spoelhof B, Ray SD. Corticosteroids. In: Encyclopedia of Toxicology. Amsterdam, Netherlands: Elsevier; 2014: 1038-1042
    Google Scholar
  • 21 Xu C, Peng H, Chai W, Li X, Li R, Chen J. Inadvertent introduction of tissue coring into joints during arthrocentesis: an experimental study. Med Sci Monit 2017; 23: 3571-3577
    CrossrefPubMedGoogle Scholar